Boston Scientific increased profits $574M in 3Q
Photo | Courtesy
Boston Scientific is headquartered in Marlborough.
Marlborough medical device manufacturer Boston Scientific Corp. released its third quarter earnings report on Wednesday, which revealed a profits of $419 million.
This new figure demonstrates a positive turn around when compared to last year’s third quarter loss of $155 million.
In addition to its net income, Boston Scientific generated net sales of $2.9 billion.
On Thursday morning, Boston Scientific's stock price was trading down 0.3% at $43.60 per share on the New York Stock Exchange. By comparison, the S&P 500 was trading up 0.8%.
The company attributes its current growth to the acquisitions of Lumenis, an Israel-based surgical company specializing in urological lasers, and Farapulse, Inc., a California firm which has become the first company to commercialize a cardiac pulsed field ablation technology, according to the release.
Agreements with Canadian-owned Baylis Medical Co. Inc. and California-based Devoro Medical Inc. expanded Boston Scientific electrophysiology and structural heart product portfolios, as well as its interventional strategies for thromboemboli, per the company’s statement.
WBJ Web Partners
Most Recent
Most Recent
0 Comments